335 related articles for article (PubMed ID: 14755758)
21. Diagnostic significance of aquaporin-1 in liver tumors.
Mazal PR; Susani M; Wrba F; Haitel A
Hum Pathol; 2005 Nov; 36(11):1226-31. PubMed ID: 16260277
[TBL] [Abstract][Full Text] [Related]
22. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
Wang L; Vuolo M; Suhrland MJ; Schlesinger K
Acta Cytol; 2006; 50(3):257-62. PubMed ID: 16780018
[TBL] [Abstract][Full Text] [Related]
23. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
McKnight R; Nassar A; Cohen C; Siddiqui MT
Cancer Cytopathol; 2012 Aug; 120(4):223-9. PubMed ID: 22298472
[TBL] [Abstract][Full Text] [Related]
24. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
Xiao SY; Wang HL; Hart J; Fleming D; Beard MR
Am J Pathol; 2001 Oct; 159(4):1415-21. PubMed ID: 11583969
[TBL] [Abstract][Full Text] [Related]
25. Polyclonal carcinoembryonic antigen staining in the cytologic differential diagnosis of primary and metastatic hepatic malignancies.
Wolber RA; Greene CA; Dupuis BA
Acta Cytol; 1991; 35(2):215-20. PubMed ID: 1709323
[TBL] [Abstract][Full Text] [Related]
26. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma.
Karabork A; Kaygusuz G; Ekinci C
Pathol Res Pract; 2010 Aug; 206(8):572-7. PubMed ID: 20400233
[TBL] [Abstract][Full Text] [Related]
27. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
[TBL] [Abstract][Full Text] [Related]
28. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.
Onofre AS; Pomjanski N; Buckstegge B; Böcking A
Cancer; 2007 Aug; 111(4):259-68. PubMed ID: 17567831
[TBL] [Abstract][Full Text] [Related]
29. Metastatic hepatocellular carcinoma with CD138 positivity: an unusual mimic of multiple myeloma?
Ramalingam P; Adeagbo B; Bollag R; Lee J; Reid-Nicholson M
Diagn Cytopathol; 2008 Oct; 36(10):742-8. PubMed ID: 18773447
[TBL] [Abstract][Full Text] [Related]
30. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
Fujiwara M; Kwok S; Yano H; Pai RK
Cancer Cytopathol; 2012 Aug; 120(4):230-7. PubMed ID: 22434791
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Lei JY; Bourne PA; diSant'Agnese PA; Huang J
Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
[TBL] [Abstract][Full Text] [Related]
32. Utility of CD10 and RCCma in the diagnosis of metastatic conventional renal-cell adenocarcinoma by fine-needle aspiration biopsy.
Simsir A; Chhieng D; Wei XJ; Yee H; Waisman J; Cangiarella J
Diagn Cytopathol; 2005 Jul; 33(1):3-7. PubMed ID: 15945081
[TBL] [Abstract][Full Text] [Related]
33. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
Radhika NS; Duseja A; Rajwanshi A; Gupta SK; Sehgal S; Suri S; Chawla Y
Trop Gastroenterol; 2004; 25(3):116-20. PubMed ID: 15682657
[TBL] [Abstract][Full Text] [Related]
34. Fine needle aspiration biopsy of hepatocellular carcinoma. Value of immunocytochemical and ultrastructural studies.
Guindi M; Yazdi HM; Gilliatt MA
Acta Cytol; 1994; 38(3):385-91. PubMed ID: 7514832
[TBL] [Abstract][Full Text] [Related]
35. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy.
Anatelli F; Chuang ST; Yang XJ; Wang HL
Am J Clin Pathol; 2008 Aug; 130(2):219-23. PubMed ID: 18628090
[TBL] [Abstract][Full Text] [Related]
36. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T
Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997
[TBL] [Abstract][Full Text] [Related]
37. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
Geramizadeh B; Boub R; Rahsaz M
Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
[TBL] [Abstract][Full Text] [Related]
38. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
Fetsch PA; Powers CN; Zakowski MF; Abati A
Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
[TBL] [Abstract][Full Text] [Related]
39. CD10 immunostaining of bile canaliculi in liver biopsies: change of staining pattern with the development of cirrhosis.
Shousha S; Gadir F; Peston D; Bansi D; Thillainaygam AV; Murray-Lyon IM
Histopathology; 2004 Oct; 45(4):335-42. PubMed ID: 15469471
[TBL] [Abstract][Full Text] [Related]
40. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.
Chu P; Arber DA
Am J Clin Pathol; 2000 Mar; 113(3):374-82. PubMed ID: 10705818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]